secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2021-11-09T23:59:59+00:00
Accession:  0001818093-21-000105
Event type: leadership
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beauty Health reports record Q3, raises FY21 guidance; CEO Clint Carnell to step down, Saunders to take over
--------------------------------------------------------------------------------

- Clint Carnell steps down as CEO and director effective Dec 31, 2021; Brent Saunders to assume CEO role from Jan 1, 2022.
- Q3 net sales $68.1M (+97% YoY); delivery systems $36.2M, consumables $32.0M; adj. EBITDA $5.8M.
- Net loss $215.1M due to non-cash warrant/earn-out liability changes; adjusted net income $2.5M.
- FY21 guidance raised: net sales $245-255M (prior $230-240M); adj. EBITDA ~$30M (prior ~$25M).
- Issued $750M 1.25% convertible notes due 2026; warrant redemption raised $185.4M cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000181809321000105/0001818093-21-000105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000181809321000105/skin-20211109.htm
  HTML page:      https://secwatch.observer/filing/0001818093-21-000105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer